Author

C. Y. Loh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:database / resource· 1 Approach:microscopy & imaging analysis· 1 Assay:proteomics· 1

Frequent Co-Authors

A. K. Andiappan· 1 shared A. TAKANO· 1 shared A. Torres-Ruesta· 1 shared B. E. Young· 1 shared B. Lee· 1 shared C. M. Poh· 1 shared C. Y.-P. Lee· 1 shared D. C. Lye· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. K. Andiappan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 10, 2021

Data-driven analysis of COVID-19 reveals specific severity patterns distinct from the temporal immune response

J. Lim, G. Carissimo, Y.-H. Chan…·B. Lee

The paper identifies immune signatures associated with COVID-19 severity and temporality, revealing distinct patterns and providing tools for data analysis.

DOI 10.1101/2021.02.10.430668

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 9, 2019

Partial absence of PD-1 expression by tumor-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma: a case report

Y. SIMONI, E. Becht, S. Li…·E. W. NEWELL

This study reports the absence of PD-1 expression on EBV-specific CD8+ T cells in LELC, suggesting anti-PD1/PD-L1 therapy may not be effective for this cancer type.

DOI 10.1101/696278

humanbulk RNA-seq

𝕏 PostBluesky